Innovotech Inc.

Equities

IOT

CA45772U1049

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 15:34:07 2024-06-19 EDT			5-day change	1st Jan Change
0.115 ^CAD	+15.00%		+27.78%	+53.33%

05-22	Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020

May 28, 2020 at 08:06 am

Innovotech Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced total revenue was CAD 126,387 compared to CAD 222,021 a year ago. Net loss was CAD 115,298 compared to CAD 14,518 a year ago.

Latest news about Innovotech Inc.

Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-21	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Innovotech Inc. Announces CFO Changes	12-11	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-27	CI
Innovotech Inc. acquired 60% stake in Nou Life Sciences Inc..	23-08-24	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
Innovotech Inc. Appoints Julie Wright to Its Board of Directors	23-07-16	CI
Innovotech Inc. Announces CEO Changes	23-07-16	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23	CI
Innovosil -1 Antimicrobial Silver Works Against Candida Auris and Superbugs	23-05-15	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15	CI
Innovotech Inc. Announces Retirement of Gerard Tertzakian as Director	22-10-25	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Innovotech Inc. Announces Termination of Collaboration Agreement for Innovosil-1 Antimicrobial Silver	22-01-21	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-24	CI
Innovotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-25	CI
Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-19	CI
Innovotech Inc Announces Management Changes	21-04-14	CI
Innovotech Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
Innovotech Inc. announced that it has received CAD 0.375 million in funding	20-09-01	CI
Innovotech Inc. announced that it expects to receive CAD 0.375 million in funding	20-08-23	CI
Innovotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-11	CI

Chart Innovotech Inc.

Duration

Period

More charts

Company Profile

Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.

Sector

Biotechnology & Medical Research

Calendar

2024-07-15 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
INNOVOTECH INC.	+53.33%	3.27M
MODERNA, INC.	+35.14%	51.51B
IQVIA HOLDINGS INC.	-7.43%	39.03B
LONZA GROUP AG	+34.78%	38.91B
CELLTRION, INC.	-10.62%	26.68B
ICON PUBLIC LIMITED COMPANY	+11.63%	26.13B
ALNYLAM PHARMACEUTICALS, INC.	-17.77%	19.91B
UNITED THERAPEUTICS CORPORATION	+40.52%	13.71B
MEDPACE HOLDINGS, INC.	+30.70%	12.38B
BIO-TECHNE CORPORATION	-3.41%	11.74B

Other Biotechnology & Medical Research